Bioengineering coagulation factors for improved hemophilia treatments: Comment on: the mutation F309S increases FVIII secretion in human cell line

Rev Bras Hematol Hemoter. 2016 Jul-Sep;38(3):184-5. doi: 10.1016/j.bjhh.2016.05.001. Epub 2016 May 21.
No abstract available